New Study Reveals Widespread Drug Resistance Across 14 African Countries
On Jul. 23, 2025, results from a newly published study highlight the growing spread of drug resistance across…
GSK’s Blujepa (gepotidacin) approved by U.S. FDA for treatment of uncomplicated urinary tract infections
On Mar. 25, 2025, GSK announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin)…